Cilostazol and Prochlorperazine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cilostazol (cilostazol) and Prochlorperazine (prochlorperazine). Common drug interactions include abnormal behaviour among females and gait disturbance among males.

The phase IV clinical study analyzes what interactions people have when they take Cilostazol and Prochlorperazine. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Cilostazol?

Cilostazol has active ingredients of cilostazol. It is often used in arteriosclerosis of the extremities. eHealthMe is studying from 7,877 Cilostazol users. Check the latest studies of Cilostazol.

What is Prochlorperazine?

Prochlorperazine has active ingredients of prochlorperazine. It is often used in nausea. eHealthMe is studying from 14,632 Prochlorperazine users. Check the latest studies of Prochlorperazine.



On Jul, 12, 2026

17 people who take Cilostazol and Prochlorperazine together, and have interactions are studied.

Cilostazol and Prochlorperazine drug interactions.

What are the common drug interactions of Cilostazol and Prochlorperazine, by gender? *:

female:

  1. Abnormal behaviour
  2. Alanine aminotransferase increased
  3. Altered state of consciousness (altered state of mind)
  4. Aspartate aminotransferase increased
  5. Back pain
  6. Circulatory collapse
  7. Headache (pain in head)
  8. Interstitial lung disease
  9. Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
  10. Oxygen saturation decreased

male:

  1. Gait disturbance
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Abdominal pain
  4. Anaemia (lack of blood)
  5. Asthenia (weakness)
  6. Back pain
  7. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  8. Chronic kidney disease
  9. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  10. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)

What are the common drug interactions of Cilostazol and Prochlorperazine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Gastritis (inflammation of stomach)
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Abdominal pain
  4. Back pain
  5. Chronic kidney disease
  6. Gait disturbance
  7. Gastrointestinal inflammation (inflammation of stomach and intestine)
  8. Nephrogenic anaemia (anaemia due to kidney disease)
  9. Renal failure (kidney dysfunction)

60+:

  1. Interstitial lung disease
  2. Oxygen saturation decreased
  3. Respiration (transport of oxygen from the outside air to the cells within tissues)
  4. Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Somnolence (a state of near-sleep, a strong desire for sleep)
  7. Speech disorder
  8. Staphylococcal infection (an infection with staphylococcus bacteria)
  9. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  10. Anxiety

What are the existing conditions these people have? *

  1. Pain: 4 people, 23.53%
  2. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 17.65%
  3. Periarthritis (inflammation of the external coats of an artery and of the tissues around the artery): 2 people, 11.76%
  4. Hiv Infection: 2 people, 11.76%
  5. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 11.76%
  6. Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 2 people, 11.76%
  7. Lumbar Spinal Stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone): 2 people, 11.76%
  8. Neuropathy Peripheral (surface nerve damage): 2 people, 11.76%
  9. Diabetes: 2 people, 11.76%
  10. High Blood Cholesterol: 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Cilostazol and Prochlorperazine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cilostazol and Prochlorperazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cilostazol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prochlorperazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cilostazol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prochlorperazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cilostazol and prochlorperazine (the active ingredients of Cilostazol and Prochlorperazine, respectively), and Cilostazol and Prochlorperazine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: